Jim Simons Takeda Pharmaceutical CO LTD Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 3,118,200 shares of TAK stock, worth $41.6 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,118,200
Previous 3,327,400
6.29%
Holding current value
$41.6 Million
Previous $47.5 Million
8.78%
% of portfolio
0.07%
Previous 0.07%
Shares
20 transactions
Others Institutions Holding TAK
# of Institutions
341Shares Held
76MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$175 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$161 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$66.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$56.2 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA2.9MShares$38.7 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...